Publications by authors named "Danielle Resar"

Claim this Profile
U
Untapped potential of post-exposure prophylaxis in sub-Saharan Africa: a comparative analysis of PEP implementation planning in Kenya, Mozambique, Nigeria, Uganda and Zambia.
Danielle Resar, Ambele Judith Mwamelo, Adebanjo Olowu, Janeen Drakes, Helder Macul

J Int AIDS Soc· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost thresholds for anticipated long-acting HIV pre-exposure prophylaxis products in Eastern and Southern Africa: a mathematical modelling study.
David Kaftan, Monisha Sharma, Danielle Resar, Masabho Milali, Edinah Mudimu

J Int AIDS Soc· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ensuring People Living with HIV Inform the Future of HIV Treatment in Low- and Middle-Income Countries: A Scoping Review and Recommendations for a Community-Led Research Agenda.
Danielle F Resar, Rachel Sapire, Benvy Caldwell, Sarah Jenkins, Kenly Sikwese

AIDS Behav· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Securing accelerated access to long-acting injectable cabotegravir for HIV prevention in low- and middle-income countries.
Sarah Y Jenkins, Danielle Resar, Zachary Panos, Alan Staple, Melynda Watkins

J Int AIDS Soc· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of the dual prevention pill for contraception and HIV pre-exposure prophylaxis.
Masabho P Milali, Danielle Resar, David Kaftan, Jennifer Campbell, Adebanjo Olowu

Front Reprod Health· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing the pipeline of multipurpose prevention technologies: opportunities across women's reproductive lifespans.
Anna Bershteyn, Danielle Resar, Hae-Young Kim, Ingrida Platais, Saiqa Mullick

Front Reprod Health· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study.
Jennifer Smith, Loveleen Bansi-Matharu, Valentina Cambiano, Dobromir Dimitrov, Anna Bershteyn, Danielle Resar

Lancet HIV· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applying mathematical modelling to estimate the impact of COVID-19-related VMMC service disruptions on new HIV infections in Zimbabwe.
Newton Chagoma, Tiwonge Kanyenda, Bothwell Pindiwe, Howard Nyika, Lawrence Nyazema, Danielle Resar

BMC Infect Dis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transitioning Long-Acting Products to a Generic Marketplace: What's Missing?
David H Brown Ripin, Kelly Catlin, Linda Lewis, Danielle Resar, Carolyn Amole

Clin Infect Dis· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patent foramen ovale in adults with sickle cell disease and stroke.
Sheila Razdan, John J Strouse, Anusha Reddy, Danielle F Resar, Rani K Hasan, Jon R Resar, Linda M S Resar

Am J Hematol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
More common than you think: common variable immune deficiency.
Abimbola Aderinto, Vibav Mouli, Danielle F Resar, Linda M S Resar

Case Rep Hematol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis